Search Results - Alex Z Fu
- Showing 1 - 8 results of 8
-
1
-
2
-
3
Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone... by Rohan Medhekar, Tao Ran, Alex Z. Fu, Sharmila Patel, Shuchita Kaila
Published in BMC Cancer (2022-08-01)Get full text
Article -
4
Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes by Kristy Iglay, Baanie Sawhney, Alex Z. Fu, Gail Fernandes, Michael F. Crutchlow, Swapnil Rajpathak, Kamlesh Khunti
Published in Endocrinology, Diabetes & Metabolism (2020-01-01)Get full text
Article -
5
Real‐World Treatment Patterns and Clinical Outcomes Among Patients With Triple‐Class–Exposed and BCMA‐Exposed Multiple Myeloma Within the United States by Hira S. Mian, Jennifer S. Harper, Hoa H. Le, Alex Z. Fu, Saurabh Patel, Xinke Zhang, Rafael Fonseca
Published in eJHaem (2025-10-01)Get full text
Article -
6
Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study by Aarti A. Patel, Shannon Allen Ferrante, Iris Lin, Alex Z. Fu, Alicia K. Campbell, Arlene Tieng
Published in Rheumatology and Therapy (2023-07-01)Get full text
Article -
7
Real-world Duration of Use and Dosing Frequency of Daratumumab in Patients With Multiple Myeloma in the United States by Rafael Fonseca, MD, Eric E. Chinaeke, PhD, Niodita Gupta-Werner, MD, MPH, PhD, Alex Z. Fu, PhD, Shuchita Kaila, PhD
Published in Mayo Clinic Proceedings: Innovations, Quality & Outcomes (2023-10-01)Get full text
Article -
8
Comparison of Time to Next Treatment or Death Between Front‐Line Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) Among T... by Doris K. Hansen, Santosh Gautam, Marie‐Hélène Lafeuille, Carmine Rossi, Bronwyn Moore, Anabelle Tardif‐Samson, Philippe Thompson‐Leduc, Alex Z. Fu, Annelore Cortoos, Shuchita Kaila, Rafael Fonseca
Published in Cancer Medicine (2024-11-01)Get full text
Article
